Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000930413-10-006141)

Filing Details

Accession Number:: 0000930413-10-006141
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-20 18:13:52
Reporting Period:: 2010-12-15

Filing Date:: 2010-12-20
Accepted Time:: 2010-12-20 18:13:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
316253	Enzo Biochem Inc	ENZ	Services-Medical Laboratories (8071)	132866202

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286811	W Carl Balezentis	C/O Enzo Biochem, Inc. 527 Madison Avenue New York NY 10022	Pres., Enzo Life Sciences	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01	Disposition	2010-12-15	12,724	$5.12	25,950	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Includes 4,783 shares of the Company's common stock, par value $0.01 per share, held in the Company's 401(k) plan.